Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Radient Technologies Inc. (V:RTI)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for RTI within the last 6 months
See all filings within the past 6 months

Company News

Nov 30, 2020 18:30 ET
Radient Technologies Inc. Announces Second Quarter 2021 Financial Results and Provides a Corporate Update
Edmonton, Alberta--(Newsfile Corp. - November 30, 2020) - Radient Technologies Inc. (TSXV: RTI) (OTCQX: RDDTF) ("Radient" or the "Company"), a manufacturer of high quality cannabinoids based formulations and products today announced its results for the second quarter ended September 30, 2020 and provided an update on its recent corporate developments.
Read full article
Nov 27, 2020 07:30 ET
Radient Technologies Announces Receipt of Cannabis Research Licence for Human Administration Trials and Sensory and Taste Evaluation of Cannabis Products
Edmonton, Alberta--(Newsfile Corp. - November 27, 2020) - Radient Technologies Inc. (TSXV: RTI) (OTCQX: RDDTF) ("Radient" or the "Company"), is pleased to announce that it has received its Cannabis Research Licence under Health Canada's Cannabis Act and Cannabis Regulations. This license permits Radient to expand its research activities by allowing the controlled administration of cannabis to human subjects to complete a comprehensive evaluation of sensory preferences.
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 30, 202070,692-9,341
Nov 15, 202080,033-402,400
Oct 31, 2020482,433348,560
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Radient Technologies Inc. is a commercial manufacturer of cannabinoid-based formulations, ingredients and related products. The Company has developed its own extraction process, Microwave Assisted Processing (MAP), which is capable of producing a consistent product at industrial scale quantities. The MAP process is continuous flow, delivers full spectrum extraction and recovers up to 99% of the active compounds from cannabis and hemp. The Company operates in Canada and is building an additional facility in Germany.

See business summary



Search (past week) for $RTI.CA RTI.V

  • No tweets found